Aktienanalyse zu United-Guardian Inc (UG)UGUnited-Guardian Inc

United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial. It operates in the Healthcare sector (PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS industry).

United-Guardian Inc is currently not a strong buy due to mixed signals in its performance and market conditions. The stock's current price is $7.15, with a forward P/E ratio of 26.53 indicating potential overvaluation compared to its historical performance. Additionally, the RSI is at 45.37, suggesting the stock is neither overbought nor oversold, which implies caution for new investors. The main risk is the recent decline in revenue by 13.5% year-over-year, reflecting challenges in the market environment, which could impact future profitability.